Intravenous zoledronate improves bone density in adults with cystic fibrosis (CF)

Ian Chapman, Hugh Greville, Peter Robert Ebeling, Susannah Jane King, Tom C Kotsimbos, Patricia Nugent, Rosie Player, Duncan J Topliss, Janet Warner, John W Wilson

Research output: Contribution to journalArticleResearchpeer-review

27 Citations (Scopus)


Reduced bone mineral density (BMD) and increased rates of atraumatic fracture are observed in cystic fibrosis (CF) patients, causing increasing morbidity as this population ages. The study aimed to assess the safety, tolerability and effect on BMD of intravenous zoledronate in adults with CF and osteopenia.
Original languageEnglish
Pages (from-to)838 - 846
Number of pages9
JournalClinical Endocrinology
Issue number6
Publication statusPublished - 2009

Cite this